Ahmed Hamdy
Chief Executive Officer at VINCERX PHARMA, INC.
Net worth: 2 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pablo D. T. Valenzuela | M | - |
Andes Biotechnologies Global, Inc.
 Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA.
Andes Biotechnologies SA
 Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 16 years |
| Raquel Izumi | M | 54 | 8 years | |
| Marc Dunoyer | M | 71 | 11 years | |
| Jeffrey Pott | M | - | 29 years | |
| Laura Bushnell | F | 56 |
Baskin School of Engineering
| 5 years |
| Luis O. Burzio | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 16 years |
| Michel Demaré | M | 67 | 5 years | |
| Richard Slavin | M | - |
The Palo Alto Medical Foundation
| - |
| Alexander Seelenberger Farba | M | 45 |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 15 years |
| Deborah DiSanzo | F | 64 | 7 years | |
| Shu Kam Mok | M | 63 | 5 years | |
| John Lee | M | 56 | 4 years | |
| Ruth Stevens | M | 64 | 3 years | |
| Pam Cheng | F | 53 | 9 years | |
| Francisco Salva | M | 53 | 4 years | |
| Patricio Cáceres | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| Cristian Hernández-Cuevas | M | - |
Andes Biotechnologies SA
Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
| Aradhana Sarin | M | 50 | 3 years | |
| Pascal Soriot | M | 64 | 12 years | |
| Sherilyn McCoy | F | 65 | 7 years | |
| Brian Druker | M | 68 | 4 years | |
| Marcus Wallenberg | M | 68 | 25 years | |
| Tom Thomas | M | 64 | 6 years | |
| Philip Broadley | M | 63 | 7 years | |
| Nazneen Rahman | M | - | 7 years | |
| Soo In Hwang | M | 64 | 6 years | |
| Tasheda Navarro | F | - | 3 years | |
| Helen MacPhee | F | 64 | - | |
| Bill Donaldson | M | - | - | |
| Melissa Merrick | F | - | 3 years | |
| Amy Johnson | M | - | 3 years | |
| Iskra Reic | F | - | 23 years | |
| Jonathan Thomas Charles Slade | M | 59 | - | |
| Josie Afolabi | F | - | 14 years | |
| Jennifer Taubert | F | 60 | 19 years | |
| David Fredrickson | M | - | 7 years | |
| Sjoerd Hubben | M | - | 8 years | |
| Elizabeth Forminard | F | 53 | 18 years | |
| Cindy Hoots | F | 56 | 4 years | |
| Alberto Hegewisch | M | - | 1 years | |
| Regina Danielson | M | 60 | - | |
| Susan Mary Galbraith | M | - | 14 years | |
| Tyrell J. Rivers | M | 51 | 10 years | |
| Adrian Charles Noel Kemp | M | 58 | 15 years | |
| Robert Jaunich | M | 84 |
The Palo Alto Medical Foundation
| - |
| Elizabeth Dávila | F | 80 |
The Palo Alto Medical Foundation
| - |
| Dan Maydan | M | 88 |
The Palo Alto Medical Foundation
| 21 years |
| James Wilson | M | 80 |
The Palo Alto Medical Foundation
| - |
| Kevin Lokay | M | 67 | 6 years | |
| Susan B. Ford-Dorsey | F | 69 |
The Palo Alto Medical Foundation
| - |
| Andreas Rummelt | M | 66 | 3 years | |
| Elizabeth Vilardo | M | - |
The Palo Alto Medical Foundation
| 9 years |
| Margaret A. Taylor | F | - |
The Palo Alto Medical Foundation
| - |
| Bob S. Hu | M | - |
The Palo Alto Medical Foundation
| - |
| Susan Ford Dorsey | F | - |
The Palo Alto Medical Foundation
| - |
| Martin Entwistle | M | - |
The Palo Alto Medical Foundation
| - |
| Paul Tang | M | - |
The Palo Alto Medical Foundation
| - |
| Elsa Johnson | F | - | - | |
| Diana Layfield | F | - | 4 years | |
| Ruud Dobber | M | - | 27 years | |
| Margareta Elisabeth Björk | M | 63 | 22 years | |
| Anna Olive Magdelene Manz | F | 51 | 1 years | |
| Euan Ashley | M | - | 4 years | |
| Sharon Barr | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Richard Miller | M | 73 | 17 years | |
| Robert Duggan | M | 79 | 7 years | |
| Ramses Erdtmann | M | 60 | 6 years | |
| Simon Lowth | M | 62 | 6 years | |
| Mahkam Zanganeh | M | 52 | 7 years | |
| Joseph Papa | M | 68 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | 3 years |
| Leif Valdemar Johansson | M | 73 | 11 years | |
| Leiv Lea | M | 70 | 11 years | |
| Glenn C. Rice | M | 68 | 2 years | |
| Joseph Peter | M | 60 | - | |
| José Baselga | M | 65 | 2 years | |
| Briggs Morrison | M | 65 | 3 years | |
| David Smith | M | - | 9 years | |
| Donald Bruce Burlington | M | 75 | 7 years | |
| Minesh P. Mehta | M | 65 | - | |
| Shriti Vadera | F | 62 | 7 years | |
| Menelas Pangalos | M | 57 | 13 years | |
| Carla Sivak | F | - | 4 years | |
| Jacques Dumas | M | 58 | 7 years | |
| Lisa Romanko | F | - | 19 years | |
| Geneviéve B. Berger | M | 69 | 9 years | |
| Mark McCamish | M | 72 | 1 years | |
| Nancy Rothwell | M | 68 | 9 years | |
| Christopher Lowe | M | 56 | 2 years | |
| Graham Chipchase | M | 61 | 9 years | |
| Charles O. Prince | M | 74 | 17 years | |
| John Varley | M | 67 | 9 years | |
| Rudolph Markham | M | 78 | 11 years | |
| Andrew McDonald | M | 50 | 2 years | |
| Michael Johns | M | 82 | 9 years | |
| Eric Hedrick | M | 59 | 2 years | |
| David Duane Smith | M | 52 | - | |
| James N. Lowder | M | 74 | - | |
| James A. Nash | M | 73 |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | - |
| Jean-Philippe Courtois | M | 63 | 8 years | |
| Michael Zinda | M | 53 | 16 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 49 | 49.00% |
| United States | 48 | 48.00% |
| Chile | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ahmed Hamdy
- Personal Network